Annual EBIT
-$170.22 M
+$5.70 M+3.24%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual earnings before interest & taxes is currently -$170.22 million, with the most recent change of +$5.70 million (+3.24%) on 31 December 2023. During the last 3 years, it has fallen by -$36.23 million (-27.04%). RYTM annual EBIT is now -1509.97% below its all-time high of -$10.57 million, reached on 31 December 2015.RYTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$38.74 M
-$11.56 M-42.55%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly earnings before interest & taxes is currently -$38.74 million, with the most recent change of -$11.56 million (-42.55%) on 30 September 2024. Over the past year, it has increased by +$1.90 million (+4.68%). RYTM quarterly EBIT is now -506.40% below its all-time high of -$6.39 million, reached on 31 March 2017.RYTM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$239.13 M
+$1.90 M+0.79%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM earnings before interest & taxes is currently -$239.13 million, with the most recent change of +$1.90 million (+0.79%) on 30 September 2024. Over the past year, it has dropped by -$66.48 million (-38.51%). RYTM TTM EBIT is now -3635.76% below its all-time high of -$6.40 million, reached on 30 September 2016.RYTM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.2% | +4.7% | -38.5% |
| 3 y3 years | -27.0% | +12.2% | -57.9% |
| 5 y5 years | -117.1% | -4.4% | -72.1% |
RYTM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -144.5% | +3.2% | -42.5% | +71.6% | -57.9% | +7.0% |
| 5 y | 5 years | -144.5% | +3.2% | -42.5% | +71.6% | -79.7% | +7.0% |
| alltime | all time | -1510.0% | +3.2% | -506.4% | +71.6% | -3635.8% | +7.0% |
Rhythm Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$38.74 M(+42.5%) | -$239.13 M(-0.8%) |
| June 2024 | - | -$27.18 M(-80.1%) | -$241.03 M(-6.3%) |
| Mar 2024 | - | -$136.32 M(+269.6%) | -$257.25 M(+51.3%) |
| Dec 2023 | -$170.22 M(-3.2%) | -$36.89 M(-9.2%) | -$170.05 M(-1.5%) |
| Sept 2023 | - | -$40.65 M(-6.3%) | -$172.65 M(+1.1%) |
| June 2023 | - | -$43.40 M(-11.6%) | -$170.72 M(-0.9%) |
| Mar 2023 | - | -$49.12 M(+24.4%) | -$172.27 M(-2.1%) |
| Dec 2022 | -$175.92 M(+152.7%) | -$39.48 M(+2.0%) | -$175.92 M(-6.1%) |
| Sept 2022 | - | -$38.72 M(-13.9%) | -$187.29 M(-2.8%) |
| June 2022 | - | -$44.95 M(-14.8%) | -$192.68 M(+2.4%) |
| Mar 2022 | - | -$52.76 M(+3.8%) | -$188.15 M(+10.8%) |
| Dec 2021 | -$69.61 M(-48.0%) | -$50.85 M(+15.3%) | -$169.79 M(+12.1%) |
| Sept 2021 | - | -$44.10 M(+9.1%) | -$151.43 M(+6.9%) |
| June 2021 | - | -$40.43 M(+17.5%) | -$141.61 M(+6.4%) |
| Mar 2021 | - | -$34.40 M(+5.9%) | -$133.09 M(-0.7%) |
| Dec 2020 | -$134.00 M | -$32.49 M(-5.2%) | -$134.00 M(-1.3%) |
| Sept 2020 | - | -$34.28 M(+7.4%) | -$135.73 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$31.92 M(-9.6%) | -$138.55 M(-8.1%) |
| Mar 2020 | - | -$35.30 M(+3.1%) | -$150.78 M(+3.3%) |
| Dec 2019 | -$146.00 M(+86.2%) | -$34.22 M(-7.8%) | -$146.00 M(+5.1%) |
| Sept 2019 | - | -$37.11 M(-16.0%) | -$138.93 M(+14.8%) |
| June 2019 | - | -$44.15 M(+44.7%) | -$121.06 M(+31.7%) |
| Mar 2019 | - | -$30.52 M(+12.4%) | -$91.94 M(+17.2%) |
| Dec 2018 | -$78.42 M(+141.9%) | -$27.15 M(+41.1%) | -$78.42 M(+26.0%) |
| Sept 2018 | - | -$19.24 M(+28.1%) | -$62.25 M(+21.4%) |
| June 2018 | - | -$15.02 M(-11.6%) | -$51.29 M(+19.2%) |
| Mar 2018 | - | -$17.00 M(+54.8%) | -$43.02 M(+32.7%) |
| Dec 2017 | -$32.41 M(+25.1%) | -$10.98 M(+32.5%) | -$32.41 M(+8.8%) |
| Sept 2017 | - | -$8.29 M(+22.7%) | -$29.80 M(+6.8%) |
| June 2017 | - | -$6.75 M(+5.7%) | -$27.92 M(+31.9%) |
| Mar 2017 | - | -$6.39 M(-23.7%) | -$21.16 M(+43.2%) |
| Dec 2016 | -$25.91 M(+145.0%) | -$8.38 M(+30.8%) | -$14.78 M(+130.8%) |
| Sept 2016 | - | -$6.40 M | -$6.40 M |
| Dec 2015 | -$10.57 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual EBIT year-on-year change?
- What is Rhythm Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly EBIT year-on-year change?
- What is Rhythm Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM EBIT year-on-year change?
What is Rhythm Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of RYTM is -$170.22 M
What is the all time high annual EBIT for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual earnings before interest & taxes is -$10.57 M
What is Rhythm Pharmaceuticals annual EBIT year-on-year change?
Over the past year, RYTM annual earnings before interest & taxes has changed by +$5.70 M (+3.24%)
What is Rhythm Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of RYTM is -$38.74 M
What is the all time high quarterly EBIT for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$6.39 M
What is Rhythm Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, RYTM quarterly earnings before interest & taxes has changed by +$1.90 M (+4.68%)
What is Rhythm Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of RYTM is -$239.13 M
What is the all time high TTM EBIT for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM earnings before interest & taxes is -$6.40 M
What is Rhythm Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, RYTM TTM earnings before interest & taxes has changed by -$66.48 M (-38.51%)